Cargando…
Questionnaire about the Adverse Events and Side Effects Following Botulinum Toxin A Treatment in Patients with Cerebral Palsy
Botulinum toxin A (BoNT-A) injections for treatment of spasticity in patients with cerebral palsy (CP) have been used for about two decades. The treatment is considered safe but a low frequency of adverse events (AE) has been reported. A good method to report AEs is necessary to verify the safety of...
Autores principales: | Blaszczyk, Izabela, Foumani, Nazli Poorsafar, Ljungberg, Christina, Wiberg, Mikael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663525/ https://www.ncbi.nlm.nih.gov/pubmed/26561833 http://dx.doi.org/10.3390/toxins7114645 |
Ejemplares similares
-
Botulinum Toxin in the Management of Children
with Cerebral Palsy
por: Multani, Iqbal, et al.
Publicado: (2019) -
Botulinum Toxin Treatment for Limb Spasticity in Childhood Cerebral Palsy
por: Pavone, Vito, et al.
Publicado: (2016) -
Best Clinical Practice in Botulinum Toxin Treatment for Children with Cerebral Palsy
por: Strobl, Walter, et al.
Publicado: (2015) -
Development of Treatment Concepts for the Use of Botulinum Toxin A in Children with Cerebral Palsy
por: Placzek, Richard, et al.
Publicado: (2010) -
The Effect of Botulinum Toxin-A on Chronic Muscle-Related Pain in Cerebral Palsy
por: Wong, Christian
Publicado: (2022)